Dr. Xiangdong Li 李向东
Chief Physician
Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Comprehensive diagnosis and treatment of urogenital tumors, with a focus on bladder, testicular, kidney, and prostate cancers.
Dr. Li holds a medical degree from Sun Yat-sen University and works at Sun Yat-sen University Cancer Center. The doctor specializes in the clinical management, basic research, and prevention of bladder and testicular cancers. Dr. Li has published multiple SCI papers as first author and participated in projects funded by the Guangdong Natural Science Foundation and the National Natural Science Foundation.
Name order: in Chinese the family name comes first (Li Xiangdong). Papers usually list the name as Xiangdong Li or Li X.
Selected publications
40 papers on PubMed matched by name and affiliation; 7 as first or senior author since 2016. Most recent first- or senior-author papers:
- Asian J Urol, 2026 (first author): Robot-assisted post-chemotherapy retroperitoneal lymph node dissection for metastatic non-seminomatous germ cell tumors using two distinct surgical approaches: A tertiary care experience. PubMed 41815375
- Zhonghua Nan Ke Xue, 2025 (senior author): [Influencing factors of fertility preservation decision-making in patients with testicular cancer: A qualitative study]. PubMed 40911011
- Cell Rep Med, 2024 (first author): A predictive system comprising serum microRNAs and radiomics for residual retroperitoneal masses in metastatic nonseminomatous germ cell tumors. PubMed 39672156
- Ann Surg Oncol, 2019 (first author): Correction to: Prognostic Role of the Immunoscore for Patients with Urothelial Carcinoma of the Bladder Who Underwent Radical Cystectomy. PubMed 31758282
- Ann Surg Oncol, 2019 (first author): Prognostic Role of the Immunoscore for Patients with Urothelial Carcinoma of the Bladder Who Underwent Radical Cystectomy. PubMed 31376036
- Am J Pathol, 2019 (first author): Overexpression of CEP72 Promotes Bladder Urothelial Carcinoma Cell Aggressiveness via Epigenetic CREB-Mediated Induction of SERPINE1. PubMed 30953603
- Sci Rep, 2016 (first author): Overexpression of RNF2 Is an Independent Predictor of Outcome in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy. PubMed 26869491
- World J Urol, 2015 (first author): Surveillance for patients with clinical stage I nonseminomatous testicular germ cell tumors. PubMed 25471669
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion